Skip to content

Clinical trials

Phase 2 Leukemia trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia Phase: Phase 2 Country / region: Canada Clear all

45 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20013
20023
20032
20051
20063
20073
20084
20094
20111
20122
20132
20152
20161
20181
20211
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed39
Terminated4
Recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Children's Oncology Group13
Bristol-Myers Squibb5
Novartis Pharmaceuticals5
Jazz Pharmaceuticals2
Aegera Therapeutics1
Celgene1
Cogent Biosciences, Inc.1
Daiichi Sankyo1
Herbert Irving Comprehensive Cancer Center1
Incyte Corporation1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia45
Leukemia, Myeloid, Acute12
Precursor Cell Lymphoblastic Leukemia-Lymphoma12
Recurrence8
Leukemia, Myelogenous, Chronic, BCR-ABL Positive6
Leukemia, Myeloid5
Blast Crisis4
Leukemia, Lymphocytic, Chronic, B-Cell4
Burkitt Lymphoma3
Hematologic Diseases3

Trials

Showing 1 to 25 of 45. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.